RESULTS	Sustained clearance of HCV viremia 6 months after interferon-alpha2a treatment stop was obtained in 12 of 53 patients ( 23 % ) : 6 of 27 in the IFN group ( 22 % ) and 6 of 26 ( 23 % ) in the IFN/Rib group ( NS ) .\